Lv6
3100 积分 2024-12-05 加入
Design, Synthesis, and Biological Evaluation of Pyrimido[4,5-d]pyrimidine-2,4(1H,3H)-diones as Potent and Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors against L858R/T790M Resistance Mutation
23天前
已完结
Synthetic lethality as an engine for cancer drug target discovery
1个月前
已完结
Homogeneous multi-payload antibody–drug conjugates
1个月前
已完结
Antibody–drug conjugates and bispecific antibodies targeting cancers: applications of click chemistry
1个月前
已完结
Bispecific antibodies for targeted delivery of anti-cancer therapeutic agents: A review
1个月前
已完结
Abstract LB057: Pre-clinical characterization of IBI343, a site-specifically conjugated anti-Claundin18.2 ADC, for treating solid tumors
1个月前
已关闭
Selectivity Approaches in Therapeutic Antibody Design
2个月前
已完结
LAG-3 as the third checkpoint inhibitor
2个月前
已完结
Design and Preclinical Evaluation of a Novel B7-H4–Directed Antibody–Drug Conjugate, AZD8205, Alone and in Combination with the PARP1-Selective Inhibitor AZD5305
2个月前
已完结
Reducing affinity as a strategy to boost immunomodulatory antibody agonism
3个月前
已完结
皖公网安备34019202002308
